The research referred to in 1° of Article L. 1121-1 may only be carried out after a favourable opinion has been obtained from the Committee for the Protection of Individuals referred to in Article L. 1123-1 and authorisation has been obtained from the competent authority referred to in Article L. 1123-12.
The request for an opinion from the Committee and the request for authorisation from the competent authority may or may not be submitted simultaneously, at the sponsor’s discretion.
The research mentioned in 2° of Article L. 1121-1 and non-interventional research may only be carried out after a favourable opinion has been obtained from the Committee for the Protection of Individuals mentioned in Article L. 1123-1. The sponsor sends a copy of this opinion and a summary of the research to the competent authority. At the request of the latter, the relevant Committee for the Protection of Individuals shall forward all relevant information concerning this research to the competent authority without delay.
Where the research referred to in 2° of Article L. 1121-1 appears on a list established by order of the Minister for Health issued on a proposal from the Director General of the National Agency for the Safety of Medicines and Health Products, the relevant personal data protection committee will check with the National Agency for the Safety of Medicines and Health Products that the use of the products to which the research relates presents only minimal risks.
In the event of serious doubt as to whether a research project falls into one of the three categories of research involving the human person defined in Article L. 1121-1, the relevant personal data protection committee will refer the matter to the Agence nationale de sécurité du médicament et des produits de santé for an opinion.